Quarterly report pursuant to Section 13 or 15(d)

Warrants and Derivative Liabilities (Detail Textuals)

v3.10.0.1
Warrants and Derivative Liabilities (Detail Textuals) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Feb. 28, 2018
Jun. 30, 2018
Jun. 30, 2018
Feb. 16, 2018
Jan. 31, 2018
Jan. 19, 2018
Dec. 31, 2017
Feb. 28, 2017
Class of Warrant or Right [Line Items]                
Issuance costs related to warrant liability     $ 137,191          
Warrant                
Class of Warrant or Right [Line Items]                
Value of common stock called by warrants               $ 30,000
Total number of warrants issued               125,000
Warrant | Emerald Health Sciences                
Class of Warrant or Right [Line Items]                
Number of warrants issued 3,400,000       40,800,000      
Total number of warrants issued 44,200,000              
Warrant exercise price $ 0.10              
Term of warrant 5 years              
Series D Preferred Stock | Warrant                
Class of Warrant or Right [Line Items]                
Value of common stock called by warrants             $ 115,200  
Total number of warrants issued             480,000  
Securities purchase agreement | Emerald Health Sciences                
Class of Warrant or Right [Line Items]                
Total number of warrants issued       20,400,000   20,400,000    
Warrant exercise price       $ 0.10   $ 0.10    
Securities purchase agreement | Accredited investor | Emerald Health Sciences                
Class of Warrant or Right [Line Items]                
Total number of warrants issued       3,400,000        
Warrant exercise price       $ 0.10        
Emerald Warrant Liabilities                
Class of Warrant or Right [Line Items]                
Value of common stock called by warrants       $ 5,700,000   $ 4,700,000    
Issuance costs related to warrant liability     $ 13,719          
Change in fair value of warrant liability   $ 1,504,529